Last updated 2026-07-26
- Raised $10M Series B led by Biotech Alliances International, Sep 2018
- Raised $1.6M grant, Mar 2018
Total raised
$11.6M
Last: Undisclosed Round 2018-10
Stage
Series B
Founded
2011
Headcount
3
HQ
Rosh Haayin, Israel
Sector
Health Tech & Life Sciences
About
Sealantium Medical is an Israeli biosurgery company established in 2011. It focuses on developing proprietary next-generation tissue sealants and hemostatic agents for surgical patients. The company's flagship product, sFilm-FS™, is a biodegradable and biocompatible polymeric film embedded with human fibrinogen and thrombin, designed for both open and minimally invasive surgery to control bleeding and seal tissues. Sealantium Medical has completed preclinical testing, randomized multicenter Phase I/II clinical trials, and is preparing for GMP manufacturing.
Funding history · 2 rounds · $11.6M total
2018-09
B Round
$10.0M
★ Biotech Alliances International
2018-03
Grant
$1.6M
Headcount over time
From 4 (2018-09) to 6 (2025-01) · +2 (+50%) · 13 points · source: Finder history + radar grounding
Q&A
- What is Sealantium Medical's primary focus?
- Sealantium Medical is a biosurgery company that develops proprietary next-generation tissue sealants and hemostatic agents for patients undergoing surgery.
- When was Sealantium Medical founded?
- Sealantium Medical was established in 2011.
- What is the name of Sealantium Medical's flagship product?
- The company's flagship product is sFilm-FS™, a biodegradable and biocompatible polymeric film designed to control bleeding and seal tissues during surgery.
- What is the current employee count for Sealantium Medical?
- Sealantium Medical has an employee count in the 1-10 range.
- Which investor led Sealantium Medical's Series B funding round?
- Biotech Alliances International led Sealantium Medical's Series B funding round in November 2017.
- What is the total amount of funding Sealantium Medical has raised to date?
- Sealantium Medical has raised a total of $18,000,000 USD.
- Has Sealantium Medical completed clinical studies for its product?
- Yes, Sealantium Medical announced the completion of its Phase I/II clinical study in June 2023.
Team · 2
Prof. Orgad Laub
Founder · CTO & Co-Founder
Dr. Chris Lamb
Founder · CEO & Co-Founder
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyBiomaterials & Tissue Engineering
Technologies
Materials & SubstancesPolymers
Target customers
Healthcare & Life SciencesHealthcareProviders
Business model
B2B
Highlights
1 PatentsVerified
Tags
first-aidmedical-technologiessurgerybiotechnologybiodegradablepolymershospitalscritical-caretissue-regeneration
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | sealantium-med.com |
|---|---|
| linkedin.com/company/5321254 | |
| YouTube | youtube.com/channel/UCp6QBBeFtB9kQAXFSaM1_yA |
Identifiers & details
| Founded | 2011 |
|---|---|
| Employees (exact) | 3 |
Radar intelligence
Patents
| EPO | 7 |
|---|
Web history (Wayback)
| Domain | sealantium-med.com |
|---|
Certificate / subdomain footprint
| Subdomains | 2 |
|---|
Israeli Companies Registrar (רשם החברות / ICA)
| Registrar # (ח.פ.) | 514567643 |
|---|---|
| Status | פעילה |
| Corp type | ישראלית חברה פרטית |
| Incorporated | 2011-01-31 |
| Purpose | לעסוק בכל עיסוק חוקי |
| Liability | מוגבלת |
| In violation (unfiled) | no |
| Last annual report | 2026 |
| Active charges / liens | 2 |
| Registry events | 3 — annual_report (1), charge (2) |
| Registered address | עמל 11 ראש העין |
Recent registry events
| Date | Event |
|---|---|
| 2026-06-30 | דו~ח שנתי |
| 2025-11-18 | רישום שעבוד |
| 2025-11-18 | רישום שעבוד |